Copyright
©The Author(s) 2025.
World J Diabetes. Jan 15, 2025; 16(1): 92711
Published online Jan 15, 2025. doi: 10.4239/wjd.v16.i1.92711
Published online Jan 15, 2025. doi: 10.4239/wjd.v16.i1.92711
Figure 6 Mizagliflozin regulates oxidative stress and inflammatory factors in mesangial cells exposed to high hyperglycemia.
A: Superoxide dismutase levels; B: Catalase levels; C: Glutathione peroxidase levels; D: Malondialdehyde levels; E: Tumour necrosis factor-α levels; F: Interleukin-1β levels. The data are presented as mean ± SD. aP < 0.05; bP < 0.01. n = 8, experiment duration = 3 days. MIZ: Mizagliflozin; IL: Interleukin; TNF: Tumour necrosis factor; SOD: Superoxide dismutase; CAT: Catalase; GSH-PX: Glutathione peroxidase; MDA: Malondialdehyde.
- Citation: Lin ZM, Gao HY, Shi SH, Li YT. Mizagliflozin ameliorates diabetes induced kidney injury by inhibitor inhibit inflammation and oxidative stress. World J Diabetes 2025; 16(1): 92711
- URL: https://www.wjgnet.com/1948-9358/full/v16/i1/92711.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i1.92711